New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer

Tamoxifen lowered breast cancer rates among high-risk women

Fulvestrant versus anastrozole in patients with advanced breast cancer

Reducing fat intake reduces death rates in some breast cancer patients

Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer

Breast cancer in men and women has different biological characteristics and outcomes

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer

Magnetic nanotechnology for the localisation of non-palpable breast cancers and concurrent sentinel node biopsy

Combination of eribulin and capecitabine provides clinical benefit for women with metastatic breast cancer

Ovarian suppression with tamoxifen reduced recurrence for some women with premenopausal breast cancer

Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype

Adding ultrasound to routine mammography improves cancer detection in dense breasts